Pharmaceutical Sector

Syngene Stock Price drops by 8 Percent on Weak Guidance by Management

Syngene Stock Price drops by 8 Percent on Weak Guidance by Management

Syngene stock price dropped after management issued cautious outlook during quarterly results. The company has reduced FY24 guidance due to slowdown in the US biotech segment.

Mitesh Thakkar: BUY SBI Life, Cadila HealthCare, Hindustan Unilever and Sun Pharma

Mitesh Thakkar: BUY SBI Life, Cadila HealthCare, Hindustan Unilever and Sun Pharma

Market analyst Mitesh Thakkar has suggested four BUY Calls and no SELL Call for today’s trading session.

Pfizer Vaccine Efficacy Helps Stock Markets Worldwide

Pfizer Vaccine Efficacy Helps Stock Markets Worldwide

Pfizer announced that its vaccine developed by a German health startup has 90 percent efficacy.

BUY Aurobindo Pharma with target Rs 985: Motilal Oswal

BUY Aurobindo Pharma with target Rs 985: Motilal Oswal

Research house and brokerage Motilal Oswal has suggested BUY Call for pharmaceutical major Aurobindo Pharma with a target price of Rs 985.

Rakesh Jhunjhunwala and LIC Raise Stake in Lupin

Rakesh Jhunjhunwala and LIC Raise Stake in Lupin

Ace investor Rakesh Jhunjhunwala has raised his stake in Lupin during the last quarter. Pharmaceutical sector has witnessed strong performance after COVID-19 pandemic led to lockdowns.

Wockhardt Signs Deal to Supply COVID-19 Vaccines to UK Government

Wockhardt Signs Deal to Supply COVID-19 Vaccines to UK Government

Pharmaceutical major Wockhardt has signed a deal with the UK government to supply COVID-19 vaccine under development and testing by AstraZeneca and researchers from Oxford University.

Pages